Clinical Trials Directory

Trials / Completed

CompletedNCT02407197

International T1 Multicentre CMR Outcome Study

International T1 Multicentre CMR Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,629 (actual)
Sponsor
King's College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myocardial fibrosis is the fundamental substrate for the development of heart failure. Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping. Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy. Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE. Primary endpoints: all cause and cardiovascular mortality. Secondary endpoints: arrhythmic composite and HF composite endpoints.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2017-12-01
Completion
2022-12-01
First posted
2015-04-02
Last updated
2023-03-09

Locations

4 sites across 3 countries: Australia, Germany, United Kingdom

Source: ClinicalTrials.gov record NCT02407197. Inclusion in this directory is not an endorsement.